title: Outcome of neonatal stroke in full-term infants without significant birth asphyxia.
abstract: Seven children with neonatal stroke were identified and six were followed for 13 months to 5 years (mean 28 months). Gestational age ranged between 39 and 42 weeks and none had hypoxic ischaemic encephalopathy. Focal clonic seizures were the presenting feature in six, and one presented with apnoea. The age of the first seizure ranged between 8 and 48 h (mean 26). The total number of seizures ranged between 3 and 10 (mean 5), and all seizures resolved by day 3 in all cases. CT scan showed an ischaemic infarct in six cases, and one child had a haemorrhagic infarct in the right anterior cerebral artery distribution. Phenobarbital was maintained for 3 weeks to 6 months (mean 11 weeks). None had recurrent seizures beyond the 3rd day of life and all were developing normally with no significant focal neurological deficits on follow up assessment.
  
  
  CONCLUSIONS
  Full-term infants with neonatal stroke unrelated to significant birth asphyxia have a favourable neurological outcome. Seizures appear to be restricted to the first 3 days of life. We recommend short-term treatment with anticonvulsants.
authors.affiliation: Department of Paediatrics (Neurology), King Abdulaziz University and the College of Medicine and Allied Health Sciences, Jeddah, Saudi Arabia.
authors.forename: M M
authors.initials: MM
authors.lastname: Jan
authors.forename: P R
authors.initials: PR
authors.lastname: Camfield
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D001034:Apgar Score; D001238:Asphyxia Neonatorum; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use*; D012640:Seizures / Q000209:etiology
chemical_list: D000927:Anticonvulsants; D010634:Phenobarbital